Clearline Capital LP Pfizer Inc Transaction History

Clearline Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $952,500 - $1.12 Million	-30,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $903,600 - $1.1 Million	30,000 New	30,000 $981,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $314,185 - $364,498	-9,846 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $327,477 - $347,465	9,846	9,846 $357,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.